Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.20.1
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock
January 2020 Offering
Common Stock
At The Market Offering
Common Stock
APIC
January 2020 Offering
APIC
At The Market Offering
APIC
Accumulated Deficit
Accumulated Other Comprehensive Gain (Loss)
Non-Controlling Interest
January 2020 Offering
At The Market Offering
Total
Balance at Dec. 31, 2018     $ 6,499     $ 114,883,135 $ (84,580,180) $ (19,904) $ (46,604)     $ 30,242,946
Stock-based compensation     320     2,059,984           2,060,304
Other comprehensive income (loss)               (8,189)       (8,189)
Net loss             (5,715,476)   (103,605)     (5,819,081)
Balance at Mar. 31, 2019     6,819     116,943,119 (90,295,656) (28,093) (150,209)     26,475,980
Balance at Dec. 31, 2019     6,757     118,173,843 (104,597,748) (11,250) (413,752)     13,157,850
January 2020 Investment offering, net of underwriters discounts (value) $ 4,000 $ 2,598   $ 4,102,148 $ 11,425,637         $ 4,106,148 $ 11,428,235  
Exercise of warrants     1,497     2,723,112           2,724,609
Exchange of warrants     447     772,883           773,330
Stock issuance costs           (452,934)           (452,934)
Issuance of common stock from vesting of restricted stock awards     328     (328)            
Stock-based compensation           948,192           948,192
Other comprehensive income (loss)               218,804       218,804
Net loss             (6,292,106)   (81,314)     (6,373,420)
Balance at Mar. 31, 2020     $ 15,627     $ 137,692,553 $ (110,889,854) $ 207,554 $ (495,066)     $ 26,530,814